NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 49 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,225 | -82.9% | 7,490 | -75.0% | 0.00% | – |
Q2 2022 | $13,000 | -65.8% | 30,000 | 0.0% | 0.00% | – |
Q1 2022 | $38,000 | -2.6% | 30,000 | 0.0% | 0.00% | – |
Q4 2021 | $39,000 | -37.1% | 30,000 | -0.0% | 0.00% | – |
Q3 2021 | $62,000 | +24.0% | 30,014 | -5.3% | 0.00% | – |
Q2 2021 | $50,000 | -37.5% | 31,706 | -11.3% | 0.00% | – |
Q1 2021 | $80,000 | -22.3% | 35,751 | -14.3% | 0.00% | – |
Q4 2020 | $103,000 | +37.3% | 41,721 | +37.1% | 0.00% | – |
Q3 2020 | $75,000 | -38.0% | 30,436 | -10.7% | 0.00% | – |
Q2 2020 | $121,000 | +55.1% | 34,073 | +1.5% | 0.00% | – |
Q1 2020 | $78,000 | +6.8% | 33,578 | +0.2% | 0.00% | – |
Q4 2019 | $73,000 | +217.4% | 33,509 | +112.6% | 0.00% | – |
Q2 2019 | $23,000 | -53.1% | 15,765 | +35.1% | 0.00% | – |
Q1 2018 | $49,000 | -35.5% | 11,672 | -41.5% | 0.00% | – |
Q3 2017 | $76,000 | +1.3% | 19,951 | -29.6% | 0.00% | – |
Q4 2016 | $75,000 | +13.6% | 28,359 | +39.4% | 0.00% | – |
Q3 2016 | $66,000 | -1.5% | 20,342 | +1.5% | 0.00% | – |
Q2 2016 | $67,000 | +36.7% | 20,042 | -0.2% | 0.00% | – |
Q1 2016 | $49,000 | -26.9% | 20,082 | -0.7% | 0.00% | – |
Q4 2015 | $67,000 | – | 20,225 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Citizens Financial Corp | 35,100 | $82,000 | 0.11% |
Patriot Financial Group Insurance Agency, LLC | 71,060 | $166,000 | 0.08% |
Willow Creek Wealth Management Inc. | 24,224 | $57,000 | 0.03% |
WEBSTER BANK, N. A. | 60,000 | $140,000 | 0.02% |
HighPoint Advisor Group LLC | 34,000 | $98,000 | 0.02% |
Brown Advisory Securities, LLC | 28,000 | $60,000 | 0.02% |
WMS Partners, LLC | 18,000 | $42,000 | 0.01% |
WEDBUSH SECURITIES INC | 33,900 | $79,000 | 0.01% |
ExodusPoint Capital Management, LP | 56,618 | $132,000 | 0.01% |
Qube Research & Technologies Ltd | 66,800 | $156,000 | 0.01% |